Is This FDA-approved - Search News

Novo Nordisk’s Ozempic Gets FDA Approval

CNBC on MSN · 9h

FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

CNN on MSN · 7h

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

The New York Times · 8h

F.D.A. Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both type 2 diabetes and chronic kidney disease.

FDA approves antidepressant nasal spray

Medical News Today · 1d

FDA-approved nasal spray for severe depression can lead to remission

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

Popular Science · 6d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

CNN on MSN · 7d

FDA approves standalone use of J&J’s ketamine-derived depression treatment

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Managed Healthcare Executive1d

FDA Approves New IV Maintenance Dose of Leqembi

A monthly 10 mg/mL maintenance dose of Leqembi had the same effects on mild Alzheimer’s symptoms as biweekly dose, research ...

The American Journal of Managed Care14h

FDA Approves Trastuzumab Deruxtecan for HER2-Low/Ultralow Breast Cancer

The approval is based on findings from a phase 3 study which demonstrated the drug’s superiority over chemotherapy.

FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

4d

Charlotte’s Web Founder Aims For FDA Approval Of Autism Spectrum Disorder Drug

Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results